Huaxi Biotech's pilot platform has been honored with the five-star rating of the first batch of national-level bio-manufacturing pilot capacity building platforms.

In the "List of Pilot Capacity Building Platforms for Biological Manufacturing (First Batch)" jointly announced by the Ministry of Industry and Information Technology and the National Development and Reform Commission, Bloomage Biotechnology (Tianjin) Co., Ltd. made it onto the list of the first batch of only five national-level units awarded the "Five-Star" service capacity, thanks to its pilot achievement transformation platform for biological manufacturing and its outstanding comprehensive service capabilities. This platform has obtained the "Five-Star" service certification in key fields such as cosmetics, food additives, and biopharmaceuticals, fully demonstrating its leading position in the field of biological manufacturing.

This cultivation and selection of pilot platforms is an important measure to implement the "Implementation Opinions on the Innovation and Development of Pilot Testing in the Manufacturing Industry". It focuses on 3 major tracks and 9 fields. Adhering to market leadership and demand guidance, it conducts targeted cultivation of pilot platforms around the major needs and typical scenarios in each link of technology R & D, achievement transfer, and commercial application. Pilot platforms are encouraged to provide paid services according to market principles and achieve stable operations. The aim is to create a number of pilot platforms with exemplary and leading roles, and accelerate the important process of transforming scientific and technological achievements from the laboratory to industrialization.

Thanks to its outstanding advantages in fermentation engineering optimization, efficient extraction of active substances, and industrial application, Bloomage Biotechnology fully meets the strict standards of the four major modules in the "Guidelines for the Cultivation of Biological Manufacturing Pilot Platforms", including technical equipment conditions, public infrastructure construction, service capabilities and qualifications, and intellectual property protection. At the same time, after being recommended by the provincial industry and information technology department and strictly reviewed by an expert panel, it successfully made it onto the list of the first batch of national-level pilot platforms. This authoritative recognition not only reflects the company's technological accumulation and innovation ability in the field of biological manufacturing, but also provides an important support platform for deepening industry-university-research collaborative innovation. Currently, Bloomage's pilot platform has served more than 20 external enterprises and completed more than 30 projects on transforming scientific and technological achievements into industrialization. This platform will effectively promote the transformation of cutting-edge research results from universities and research institutions to the industrial end, and shorten the marketization cycle of innovative products.

As a leading enterprise in the field of biotechnology, Bloomage Biotechnology has always adhered to synthetic biology as its core driving force and built a complete innovation chain from basic research to industrial implementation. The company's full-process innovation system of "R & D - Pilot - Industrialization" provides a solid guarantee for the efficient transformation of biological active substances. This pilot platform is equipped with world-class fermentation systems, purification equipment, and testing instruments, and has 64 flexible pilot production lines, which can simultaneously carry out large-scale transformation work on six major categories of biological active substances. Its service scope covers multiple strategic emerging industries such as medical and health, beauty and personal care, and functional food.

Looking to the future, Bloomage Biotechnology will give full play to the exemplary and leading role of the national-level platform, actively cooperate with upstream and downstream partners in the industrial chain, and jointly provide systematic solutions for customers. It aims to achieve the incubation from achievements to products and then to commodities, and jointly build a biotechnology innovation ecosystem. The company will continue to increase R & D investment, improve the efficiency of pilot transformation, and accelerate the industrialization process of biotechnology achievements, contributing to the high-quality development of the industry. By collaborating with upstream and downstream partners to build an industrial ecological alliance, forming an industrial cluster effect, and jointly promoting industrial cooperation and win - win results, a highly efficient and collaborative industrial ecological closed - loop will be established, which will strongly promote the biological manufacturing industry into the 5.0 era. At the same time, Bloomage Biotechnology will also take this as an opportunity to further consolidate its leading technological position in the global biological manufacturing field, inject strong impetus into the implementation of the Healthy China Strategy and the take - off of the bio - economy, and help China's biotechnology industry reach the international first - class level.